Activity of fludarabine in patients (PTS) with de novo B-cell prolymphocytic leukemia (PLL) and the prolymphocytoid variant of chronic lymphocytic leukemia (CLL-PRO).

被引：0
|
作者：
Rodríguez, J [1 ]
O'Brien, S [1 ]
Lerner, S [1 ]
Cortés, J [1 ]
Kantarjian, H [1 ]
Keating, M [1 ]
机构：
[1] Univ Texas, Md Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
423
引用
收藏
页码：104A / 104A
页数：1
相关论文
共 50 条
  • [31] T-cell function in patients with B-cell chronic lymphocytic leukemia (B-CLL) following alemtuzumab (Campath®) or fludarabine treatment.
    Kiaii, S
    Mozaffari, F
    Lundin, J
    Rezvany, R
    Chudhury, A
    Mellstedt, H
    Osterborg, A
    [J]. BLOOD, 2004, 104 (11) : 689A - 689A
  • [32] B-cell prolymphocytic leukemia with translocation 11;14: is it B-PLL or is it a leukemic variant of mantle cell lymphoma?
    Tirado, CA
    Golembiewski-Ruiz, V
    Moore, JO
    Buckley, PJ
    Goodman, BK
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 227 - 227
  • [33] The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia (B-CLL) is decreased by thalidomide and fludarabine treatment
    Giannopoulos, K.
    Schmitt, M.
    Wlasiuk, P.
    Chen, J.
    Bojarska-Junak, A.
    Kowal, M.
    Rolinski, J.
    Dmoszynska, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 190 - 190
  • [34] THERAPEUTIC LEUKAPHERESIS IN A PATIENT WITH PROLYMPHOCYTIC TRANSFORMATION OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    STEENSSENS, L
    VANCAMP, B
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1984, 7 (03): : 139 - 142
  • [35] Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC) In Relapsed/Refractory Patients with B-Cell Chronic Lymphocytic Leukemia (CLL): Final Report of the Italian Study
    Montillo, Marco
    Tedeschi, Alessandra
    Ricci, Francesca
    Zaccaria, Alfonso
    Crugnola, Monica
    Spriano, Mauro
    Spedini, PierAngelo
    Ilariucci, Fiorella
    Uziel, Lilj
    Attolico, Immacolata
    De Blasio, Angelo
    Vismara, Eleonora
    Morra, Enrica
    Petrizzi, Valeria Belsito
    [J]. BLOOD, 2010, 116 (21) : 595 - 596
  • [36] TNF family molecules in the serum of patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Jablonska, E
    Kiersnowska-Rogowska, B
    Rogowski, F
    Parfienczyk, A
    Puzewska, W
    Bukin, M
    [J]. LEUKEMIA & LYMPHOMA, 2005, 46 (09) : 1307 - 1312
  • [37] Surface and cytoplasmic immunoglobulin expression in B-cell chronic lymphocytic leukemia (CLL)
    Lewis, RE
    Cruse, JM
    Pierce, S
    Lam, J
    Tadros, Y
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2005, 79 (02) : 146 - 150
  • [38] Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
    Kent, SA
    Peterson, LC
    James, C
    Goolsby, CL
    [J]. MODERN PATHOLOGY, 2001, 14 (01) : 168A - 168A
  • [39] CYTOGENETIC FINDINGS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - A PROGRESS REPORT
    HAN, T
    EMRICH, L
    SADAMORI, N
    OTAKI, K
    BLOCK, AW
    GOMEZ, GA
    OZER, H
    HENDERSON, ES
    BLOOM, ML
    SANDBERG, AA
    [J]. EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 535 - 535
  • [40] Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Giannopoulos, K.
    Dmoszynska, A.
    Bojarska-Junak, A.
    Schmitt, M.
    Rolinski, J.
    [J]. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (04) : 457 - 460
12345